ERNEST HAWK to United States
This is a "connection" page, showing publications ERNEST HAWK has written about United States.
Connection Strength
0.475
-
Recent American College of Physicians Guidance Statement for Screening Average-risk, Asymptomatic Adults for Colorectal Cancer. Cancer Prev Res (Phila). 2024 01 04; 17(1):1-5.
Score: 0.067
-
A Comprehensive Program to Reduce Tobacco-related Cancers Through Actions by a National Cancer Institute-designated Cancer Center. Cancer Control. 2022 Jan-Dec; 29:10732748221138713.
Score: 0.058
-
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health. Cancer Prev Res (Phila). 2018 12; 11(12):735-778.
Score: 0.047
-
Cancer Prevention Recommendations: Impact of Adherence. Semin Oncol Nurs. 2016 08; 32(3):306-13.
Score: 0.040
-
Ernest Hawk Discusses the NCI-Designated Cancer Centers' Joint Statement on the HPV Vaccine. Oncology (Williston Park). 2016 Jul; 30(7):599-600.
Score: 0.040
-
Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement. Cancer. 2014 Apr 01; 120 Suppl 7:1113-21.
Score: 0.034
-
Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research. Cancer Prev Res (Phila). 2010 Aug; 3(8):1044-8.
Score: 0.026
-
The Translational Research Working Group developmental pathway for lifestyle alterations. Clin Cancer Res. 2008 Sep 15; 14(18):5707-13.
Score: 0.023
-
The Translational Research Working Group developmental pathways: introduction and overview. Clin Cancer Res. 2008 Sep 15; 14(18):5664-71.
Score: 0.023
-
What is the future of oncology? National Cancer Institute initiatives to improve research, development, and implementation in cancer prevention and treatment. Semin Oncol. 2006 Dec; 33(6 Suppl 11):S6-9.
Score: 0.020
-
Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018. Cancer Prev Res (Phila). 2022 11 01; 15(11):777-784.
Score: 0.015
-
Epidemiology and prevention of colorectal cancer. Surg Clin North Am. 2002 Oct; 82(5):905-41.
Score: 0.015
-
Primary cancer prevention trials. Hematol Oncol Clin North Am. 2000 Aug; 14(4):809-30.
Score: 0.013
-
Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 2000 May; 9(5):523-7.
Score: 0.013
-
Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev. 2018 07 01; 32(13-14):868-902.
Score: 0.011
-
Should CMS cover lung cancer screening for the fully informed patient? JAMA. 2014 Sep 24; 312(12):1193-4.
Score: 0.009
-
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
Score: 0.008
-
Translational Research Working Group developmental pathway for biospecimen-based assessment modalities. Clin Cancer Res. 2008 Sep 15; 14(18):5672-7.
Score: 0.006
-
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb 18; 96(4):261-8.
Score: 0.004
-
National Cancer Institute--supported cancer chemoprevention research: coming of age. J Clin Oncol. 1999 Nov; 17(11 Suppl):53-62.
Score: 0.003